The Australian medical landscape is abuzz with the emergence of retatrutide, a novel dual GIP and GLP-1 receptor showing significant results in clinical trials for addressing obesity. This medication https://bookmarkstime.com/story22476545/retatrutide-australia-a-potential-hope-for-weight-management